Invention Grant
- Patent Title: Compounds and compositions for treating conditions associated with NLRP activity
-
Application No.: US18319630Application Date: 2023-05-18
-
Publication No.: US12084424B2Publication Date: 2024-09-10
- Inventor: Luigi Franchi , Shomir Ghosh , Gary Glick , Jason Katz , Anthony William Opipari, Jr. , William Roush , Hans Martin Seidel , Dong-Ming Shen , Shankar Venkatraman , David Guenther Winkler
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Timothy P. O'Dea
- Main IPC: C07D277/36
- IPC: C07D277/36 ; C07C307/06 ; C07D215/36 ; C07D231/18 ; C07D239/26 ; C07D263/46 ; C07D307/64 ; C07D307/79 ; C07D317/62 ; C07D333/34 ; C07D487/04 ; C07C335/42 ; C07D213/71 ; C07D231/12 ; C07D405/12 ; C07D409/12 ; C07D417/12 ; C07D471/04
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:
or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
Public/Granted literature
- US20230416211A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Public/Granted day:2023-12-28
Information query
